Header Logo

Wendee Gozansky

Concepts (256)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Aging
4
2017
162
1.090
Why?
Sexual and Gender Minorities
2
2017
27
1.080
Why?
Palliative Care
5
2020
61
1.070
Why?
Goals
1
2020
30
0.710
Why?
Estrogens
4
2013
61
0.630
Why?
Bone Density
6
2014
92
0.620
Why?
Body Composition
12
2016
83
0.590
Why?
Organizational Objectives
1
2017
18
0.570
Why?
Aged
22
2020
6150
0.560
Why?
Program Development
1
2017
69
0.550
Why?
Community-Based Participatory Research
1
2017
61
0.550
Why?
Homosexuality
1
2016
5
0.550
Why?
Health Status Disparities
1
2017
146
0.500
Why?
Pharmacy Service, Hospital
1
2015
4
0.500
Why?
Medication Therapy Management
1
2015
6
0.500
Why?
Homosexuality, Female
1
2014
8
0.460
Why?
Cultural Competency
1
2014
12
0.460
Why?
Bisexuality
1
2014
12
0.460
Why?
Social Work
1
2014
14
0.460
Why?
Obesity
8
2016
842
0.460
Why?
Homosexuality, Male
1
2014
38
0.450
Why?
Transgender Persons
1
2014
38
0.450
Why?
Humans
38
2020
17762
0.440
Why?
Female
33
2019
12740
0.430
Why?
Weight Loss
5
2016
305
0.420
Why?
Exercise
7
2014
492
0.400
Why?
Emergency Service, Hospital
1
2015
368
0.390
Why?
Estrogen Replacement Therapy
3
2013
99
0.380
Why?
Middle Aged
24
2017
7988
0.370
Why?
Postmenopause
7
2014
242
0.360
Why?
Male
20
2019
10106
0.360
Why?
Raloxifene Hydrochloride
2
2013
12
0.350
Why?
Saliva
2
2005
12
0.310
Why?
Muscle, Skeletal
4
2012
33
0.310
Why?
Social Workers
2
2020
2
0.310
Why?
Insulin
7
2013
206
0.290
Why?
Aged, 80 and over
7
2020
1923
0.280
Why?
Adiposity
3
2013
66
0.270
Why?
Hypothalamo-Hypophyseal System
1
2005
4
0.250
Why?
Pituitary-Adrenal System
1
2005
5
0.250
Why?
Hydrocortisone
1
2005
16
0.250
Why?
Interviews as Topic
2
2017
305
0.240
Why?
Physical Endurance
1
2003
5
0.220
Why?
Hypogonadism
1
2003
4
0.220
Why?
Bone and Bones
2
2014
9
0.220
Why?
Dehydroepiandrosterone Sulfate
3
2013
5
0.200
Why?
Colorado
4
2019
164
0.200
Why?
Blood Glucose
5
2013
343
0.200
Why?
Adult
12
2016
7678
0.190
Why?
Lipid Metabolism
2
2012
13
0.180
Why?
Insulin Resistance
2
2013
134
0.180
Why?
Feasibility Studies
1
2020
114
0.180
Why?
Lipolysis
2
2013
2
0.180
Why?
Needs Assessment
2
2014
69
0.170
Why?
Caregivers
1
2020
129
0.160
Why?
Dehydroepiandrosterone
2
2011
5
0.160
Why?
Patient Reported Outcome Measures
1
2019
48
0.160
Why?
Ambulatory Care Facilities
1
2019
69
0.160
Why?
Subcutaneous Fat
2
2010
3
0.160
Why?
Glycerol
4
2013
4
0.160
Why?
Culturally Competent Care
1
2018
11
0.160
Why?
Advance Care Planning
1
2018
12
0.160
Why?
Gonadotropin-Releasing Hormone
2
2011
10
0.160
Why?
Patient Navigation
1
2018
15
0.160
Why?
Social Support
2
2018
206
0.150
Why?
Patient Admission
3
2015
72
0.150
Why?
Ageism
1
2016
2
0.140
Why?
Caloric Restriction
1
2016
4
0.140
Why?
Energy Metabolism
3
2013
50
0.140
Why?
Independent Living
1
2016
22
0.140
Why?
Chronic Disease
1
2019
428
0.130
Why?
Fasting
1
2016
48
0.130
Why?
Housing
1
2016
39
0.130
Why?
Hispanic Americans
1
2018
404
0.130
Why?
Focus Groups
1
2016
147
0.130
Why?
Health Personnel
1
2017
125
0.130
Why?
Skilled Nursing Facilities
1
2015
8
0.120
Why?
Qualitative Research
1
2016
256
0.120
Why?
Body Weight
3
2016
223
0.120
Why?
Health Services Needs and Demand
1
2015
93
0.120
Why?
Residence Characteristics
1
2016
250
0.110
Why?
Selective Estrogen Receptor Modulators
1
2013
11
0.110
Why?
Exercise Therapy
1
2014
71
0.110
Why?
Glucose
2
2011
30
0.110
Why?
Cognition Disorders
1
2013
31
0.110
Why?
Acetaminophen
1
2012
4
0.100
Why?
Quality Assurance, Health Care
1
2014
169
0.100
Why?
Adaptation, Physiological
1
2012
4
0.100
Why?
Resistance Training
1
2012
5
0.100
Why?
Thigh
2
2010
11
0.100
Why?
Delivery of Health Care
1
2016
415
0.100
Why?
Cognition
1
2013
83
0.100
Why?
Receptors, CCR5
1
2012
1
0.100
Why?
Cervix Uteri
1
2012
5
0.100
Why?
CD4-Positive T-Lymphocytes
1
2012
13
0.100
Why?
HIV-1
1
2012
70
0.100
Why?
Thinness
1
2012
30
0.100
Why?
Absorptiometry, Photon
4
2014
50
0.100
Why?
Dietary Fats
1
2012
91
0.100
Why?
Hormone Antagonists
1
2011
1
0.090
Why?
Hormone Replacement Therapy
2
2008
22
0.090
Why?
Sympathetic Nervous System
1
2011
3
0.090
Why?
Osteoporosis, Postmenopausal
1
2011
42
0.090
Why?
Severity of Illness Index
1
2013
455
0.090
Why?
Intra-Abdominal Fat
1
2010
14
0.090
Why?
Retrospective Studies
2
2015
2461
0.080
Why?
Weight Gain
1
2011
173
0.080
Why?
Dyslipidemias
1
2010
62
0.080
Why?
Biomarkers
4
2012
303
0.080
Why?
Neuropsychological Tests
2
2013
41
0.080
Why?
Muscle Strength
1
2008
12
0.080
Why?
Motor Activity
1
2008
212
0.070
Why?
Life Expectancy
1
2006
33
0.060
Why?
Health Status Indicators
1
2006
64
0.060
Why?
Health Status
1
2008
298
0.060
Why?
Corticotropin-Releasing Hormone
1
2005
1
0.060
Why?
Radioimmunoassay
1
2005
4
0.060
Why?
Carrier Proteins
1
2005
13
0.060
Why?
Immunoenzyme Techniques
1
2005
20
0.060
Why?
Dexamethasone
1
2005
12
0.060
Why?
Glucocorticoids
1
2005
20
0.060
Why?
Area Under Curve
3
2013
34
0.060
Why?
Exercise Test
1
2005
44
0.060
Why?
HIV Infections
1
2012
696
0.060
Why?
Menstrual Cycle
1
2005
5
0.060
Why?
Basal Metabolism
1
2005
5
0.060
Why?
Adipose Tissue
1
2005
58
0.060
Why?
Radioisotope Dilution Technique
1
2004
1
0.060
Why?
Deuterium
1
2004
3
0.060
Why?
Body Water
1
2004
3
0.060
Why?
Serum
1
2004
3
0.060
Why?
Urine
1
2004
5
0.060
Why?
Sensitivity and Specificity
1
2005
304
0.060
Why?
Pilot Projects
2
2016
218
0.060
Why?
Glucose Clamp Technique
3
2013
13
0.060
Why?
Contraceptives, Oral, Hormonal
1
2004
12
0.060
Why?
Hypoventilation
1
2004
1
0.060
Why?
Sleep Apnea Syndromes
1
2004
8
0.060
Why?
Education, Medical, Graduate
1
2003
18
0.050
Why?
Surveys and Questionnaires
2
2019
1321
0.050
Why?
Thiazolidinediones
1
2003
52
0.050
Why?
Terminal Care
1
2003
41
0.050
Why?
Length of Stay
1
2004
181
0.050
Why?
Internship and Residency
1
2003
45
0.050
Why?
Transcription, Genetic
2
2012
7
0.050
Why?
Lipids
2
2013
78
0.050
Why?
Collagen Type I
2
2012
6
0.050
Why?
Peptides
2
2012
12
0.050
Why?
Weight Reduction Programs
2
2014
52
0.050
Why?
Obesity, Morbid
1
2004
120
0.050
Why?
Energy Intake
2
2016
101
0.050
Why?
Treatment Outcome
2
2016
1260
0.050
Why?
Triglycerides
2
2012
88
0.050
Why?
Tomography, X-Ray Computed
2
2014
210
0.050
Why?
Calorimetry
2
2012
2
0.050
Why?
Fatty Acids
2
2012
8
0.050
Why?
Linear Models
3
2008
231
0.050
Why?
Hypoglycemic Agents
1
2003
271
0.040
Why?
Diet
3
2009
365
0.040
Why?
Health Knowledge, Attitudes, Practice
1
2003
382
0.040
Why?
Cardiovascular Diseases
1
2005
599
0.040
Why?
Hip
2
2011
9
0.040
Why?
Placebos
2
2011
21
0.040
Why?
Body Mass Index
3
2011
964
0.040
Why?
Lumbar Vertebrae
2
2011
19
0.040
Why?
Glucose Tolerance Test
2
2013
108
0.040
Why?
Kinetics
2
2012
12
0.040
Why?
Heart Failure
1
2003
396
0.040
Why?
Double-Blind Method
2
2008
155
0.040
Why?
Streptococcus agalactiae
1
1997
8
0.030
Why?
Randomized Controlled Trials as Topic
1
2018
328
0.030
Why?
Cross-Sectional Studies
2
2013
1330
0.030
Why?
Streptococcal Infections
1
1997
22
0.030
Why?
Diet, Reducing
1
2016
25
0.030
Why?
Physical Fitness
2
2008
73
0.030
Why?
Injections, Intravenous
2
2006
10
0.030
Why?
Population Surveillance
1
1997
264
0.030
Why?
Follow-Up Studies
2
2011
1213
0.030
Why?
Predictive Value of Tests
2
2008
354
0.030
Why?
Femur Neck
1
2014
5
0.030
Why?
Executive Function
1
2013
23
0.030
Why?
Mathematical Concepts
1
2013
3
0.030
Why?
Osteogenesis
1
2012
2
0.030
Why?
Alkaline Phosphatase
1
2012
7
0.030
Why?
Reference Values
1
2013
92
0.030
Why?
HLA-DR Antigens
1
2012
2
0.030
Why?
ADP-ribosyl Cyclase 1
1
2012
2
0.020
Why?
DNA
1
2012
22
0.020
Why?
Statistics, Nonparametric
1
2012
50
0.020
Why?
Phosphorylation
1
2012
4
0.020
Why?
Oxidation-Reduction
1
2012
5
0.020
Why?
Disease Susceptibility
1
2012
37
0.020
Why?
Muscle Proteins
1
2012
5
0.020
Why?
Polymerase Chain Reaction
1
2012
49
0.020
Why?
Gene Expression Regulation
1
2012
23
0.020
Why?
Bone Remodeling
1
2011
5
0.020
Why?
Dinoprostone
1
2011
2
0.020
Why?
Oxytocics
1
2011
2
0.020
Why?
Cholesterol
1
2011
106
0.020
Why?
Gonadal Steroid Hormones
1
2011
26
0.020
Why?
Cholesterol, HDL
1
2011
81
0.020
Why?
Heart Rate
1
2011
41
0.020
Why?
Cholesterol, LDL
1
2011
119
0.020
Why?
Risk Factors
2
2010
3356
0.020
Why?
Oxygen Consumption
1
2009
10
0.020
Why?
Physical Exertion
1
2009
22
0.020
Why?
Case-Control Studies
1
2012
1120
0.020
Why?
Blood Pressure
1
2011
302
0.020
Why?
Analysis of Variance
1
2009
159
0.020
Why?
Insulin-Like Growth Factor I
1
2008
13
0.020
Why?
Testosterone
1
2008
22
0.020
Why?
Sex Hormone-Binding Globulin
1
2008
22
0.020
Why?
Age Factors
1
2011
918
0.020
Why?
Patient Selection
1
2009
190
0.020
Why?
Sex Factors
1
2010
644
0.020
Why?
Regression Analysis
1
2008
300
0.020
Why?
Carbon Isotopes
1
2006
1
0.020
Why?
Microdialysis
1
2006
1
0.020
Why?
Cross-Over Studies
1
2006
46
0.020
Why?
Femur
1
2006
10
0.020
Why?
Calcium, Dietary
1
2006
27
0.020
Why?
Time Factors
1
2009
1093
0.020
Why?
Sex Characteristics
1
2006
69
0.020
Why?
Buttocks
1
2005
1
0.020
Why?
Vitamin D
1
2006
76
0.020
Why?
Abdomen
1
2005
20
0.020
Why?
Follicular Phase
1
2005
1
0.020
Why?
Luteal Phase
1
2005
1
0.020
Why?
Premenopause
1
2005
24
0.020
Why?
Reproducibility of Results
1
2006
381
0.020
Why?
Young Adult
1
2012
2461
0.020
Why?
Rest
1
2004
3
0.010
Why?
C-Peptide
1
2004
6
0.010
Why?
Liver
1
2004
32
0.010
Why?
Bicarbonates
1
2004
2
0.010
Why?
Carbon Dioxide
1
2004
2
0.010
Why?
Long-Term Care
1
2004
22
0.010
Why?
Hospitals, Teaching
1
2004
17
0.010
Why?
Attitude to Death
1
2003
5
0.010
Why?
Confidence Intervals
1
2004
237
0.010
Why?
Psychometrics
1
2004
121
0.010
Why?
Hyperinsulinism
1
2003
9
0.010
Why?
Survival Analysis
1
2004
215
0.010
Why?
Estradiol
1
2003
23
0.010
Why?
Critical Care
1
2004
71
0.010
Why?
Chi-Square Distribution
1
2003
154
0.010
Why?
Clinical Competence
1
2003
99
0.010
Why?
Outcome Assessment (Health Care)
1
2004
228
0.010
Why?
Physicians
1
2003
137
0.010
Why?
Comorbidity
1
2004
597
0.010
Why?
Proportional Hazards Models
1
2004
710
0.010
Why?
Mass Screening
1
2006
677
0.010
Why?
Cohort Studies
1
2006
2586
0.010
Why?
Diabetes Mellitus, Type 2
1
2003
755
0.010
Why?
Adolescent
1
2004
3685
0.010
Why?
Infant, Newborn
1
1997
855
0.010
Why?
Concepts (256)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente